of  

or
Sign in to continue reading...

QIB Sukuk Ltd USD100 Million 1.75% 16-Oct-2023 - Final Terms

IM Insights
By IM Insights
5 years ago
QIB Sukuk Ltd USD100 Million 1.75% 16-Oct-2023 - Final Terms

Mudaraba, Sukuk


Create FREE account or Login to add your comment
Comments (0)


Transcription

  1. MIFID II PRODUCT GOVERNANCE / PROFESSIONAL INVESTORS AND ECPS ONLY TARGET MARKET– There are no manufacturers for the purposes of Directive 2014/65/EU (as amended, "MiFID II"). Any person offering, selling or recommending the Certificates (a "distributor") should consider (i) the target market for the Certificates to be eligible counterparties and professional clients only, each as defined in MiFID II, and (ii) all channels for distribution of the Certificates to eligible counterparties and professional clients to be appropriate. However, a distributor subject to MiFID II is responsible for undertaking its own target market assessment in respect of the Certificates (by either adopting or refining the target market) and determining appropriate distribution channels. APPLICABLE FINAL TERMS Final Terms dated 12 October 2018 QIB Sukuk Ltd. Issue of U.S.$100,000,000 Trust Certificates due 2023 under the U.S.$4,000,000,000 Trust Certificate Issuance Programme PART A — CONTRACTUAL TERMS Terms used herein shall be deemed to be defined as such for the purposes of the Conditions set forth in the Base Prospectus dated 4 April 2018, the supplement to the Base Prospectus dated 16 April 2018 and the supplement to the Base Prospectus dated 1 October 2018 which together constitute a base prospectus (the "Base Prospectus") for the purposes of Directive 2003/71/EC, as amended (the "Prospectus Directive"). This document constitutes the Final Terms relating to the issue of Certificates described herein for the purposes of Article 5.4 of the Prospectus Directive and must be read in conjunction with the Base Prospectus. Full information on the Trustee, QIB and the Certificates is only available on the basis of a combination of these Final Terms and the Base Prospectus. The Base Prospectus and these Final Terms have been published on the website of the Central Bank of Ireland (http://www.centralbank.ie) and are available for viewing during normal business hours at the registered offices of The Trustee at c/o MaplesFS Limited, P.O. Box 1093, Queensgate House, Grand Cayman, KY1-1102, Cayman Islands and the Principal Paying Agent at Winchester House, 1 Great Winchester Street, London EC2N 2DB, United Kingdom. 1. 2. (i)1 Trustee: QIB Sukuk Ltd. (ii) Obligor: Qatar Islamic Bank (Q.P.S.C.) (i)2 Series Number: 14 (ii) Tranche Number: 1 (iii) Date on which the Certificates will be consolidated and form a single Series: Not Applicable 3. Specified 3 Currency: U.S. dollars ("U.S.$") 4. Aggregate 4 Face Amount: U.S.$100,000,000 5. Issue 5 Price: 100 per cent. of the Aggregate Face Amount 6. (i)6 Specified Denominations: U.S.$200,000 and integral multiples of U.S.$1,000 in excess thereof (ii) Calculation Amount: U.S.$1,000 (i)7 Issue Date: 16 October 2018 (ii) Return Date: 7. 231861-4-4-v3.0 Accrual Commencement Issue Date -1- 75-40701784
  2. 8 . Scheduled 8 Dissolution Date: Periodic Distribution Date falling on or nearest to 16 October 2023 9. Periodic 9 Distribution Amount Basis: 3 month U.S.$ LIBOR + 1.75 per cent. per annum Floating Periodic Distribution Amount 10. Dissolution 1 Basis: 0 Dissolution at Par 11. Change 1 of Periodic Distribution Amount Basis: 1 Not Applicable 12. Call 1 Option: 2 Not Applicable 13. Date 1 of Board approval for issuance of Certificates 3 obtained: 9 October 2018 in the case of the Trustee and 15 September 2012 and 19 January 2016 in the case of QIB PROVISIONS RELATING TO PERIODIC DISTRIBUTIONS PAYABLE 14. Fixed 1 Periodic Distribution Provisions: 4 Not Applicable 15. Floating 1 Periodic Distribution Provisions: 5 Applicable (i) Specified Dates: 16 January, 16 April, 16 July and 16 October of each year, commencing on 16 January 2019, subject to adjustment in accordance with the Business Day Convention in 15(iv). (ii) Specified Period: Not Applicable (iii) First Periodic Distribution Date: 16 January 2019 (iv) Business Day Convention: Modified Following Business Day Convention (v) Additional Business Centres: London (vi) Manner in which the Rates are to be determined: Screen Rate Determination (Condition 9(c) (Floating Periodic Distribution Provisions — Screen Rate Determination) applies (vii) Screen Rate Determination: Applicable (a) 3 month U.S.$ LIBOR Periodic Distribution Reference Rate: (b) Periodic Distribution Determination Date: As per the Conditions (c) Relevant Screen Page: Reuters Page LIBOR01 (d) Relevant Time: 11:00 a.m. (London time) (viii) Margin: +1.75 per cent. per annum (ix) Linear Interpolation: Not Applicable (x) Day Count Fraction: Act/360 (xi) Calculation Agent: Principal Paying Agent 231861-4-4-v3.0 -2- 75-40701784
  3. PROVISIONS RELATING TO DISSOLUTION 16 . Optional 1 Dissolution Right: 6 Not Applicable 17. Dissolution 1 Amount of each Certificate: 7 U.S.$1,000 per Calculation Amount 18. Early 1 Dissolution Amount (Tax) of each Certificate 8 (following early dissolution for tax reasons): Dissolution Amount GENERAL PROVISIONS APPLICABLE TO THE CERTIFICATES 19. Form 1 of Certificates: 9 Registered Certificates Global Certificate registered in the name of a nominee for a common depositary for Euroclear and Clearstream, Luxembourg exchangeable for Certificates in definitive registered form in the limited circumstances specified in the Global Certificate. 20. Additional 2 Financial Centre(s) relating to payment: 0 Not Applicable PROVISIONS IN RESPECT OF THE TRUST ASSETS 21. Wakala/Mudaraba 2 Portfolio 1 (i) Wakala Percentage: 84.38 per cent. on the Issue Date (ii) Mudaraba Percentage: 15.62 per cent. on the Issue Date 22. Trust 2 Assets: 2 Condition 6(b) applies 23. (i)2 3 Details of Transaction Account: QIB Sukuk Ltd. Transaction Account No: GB16DEUT40508126293713 with Deutsche Bank AG, London Branch for Series No.: 14 (ii) Supplemental Declaration of Trust: Supplemental Declaration of Trust dated 16 October 2018 between the Trustee, QIB and the Delegate (iii) Supplemental Purchase Contract: Supplemental Purchase Contract dated 16 October 2018 between the Trustee and QIB (iv) Restricted Mudaraba Contract: Restricted Mudaraba Contract dated 16 October 2018 between the Trustee and QIB 231861-4-4-v3.0 -3- 75-40701784
  4. PART B — OTHER INFORMATION LISTING AND ADMISSION TO TRADING Listing and admission to trading: Application has been made by the Trustee (or on its behalf) for the Certificates to be admitted to trading on Euronext Dublin's Main Securities Market and listing on the Official List of Euronext Dublin with effect from 16 October 2018. Estimate of total expenses related to admission to trading: €1000 RATINGS Ratings: The Certificates to be issued are expected to be rated: Fitch: A Fitch is established in the European Union and registered under Regulation (EC) No. 1060/2009 (as amended) (the "CRA Regulation"). INTERESTS OF NATURAL AND LEGAL PERSONS INVOLVED IN THE ISSUE Save for any fees payable to the Dealers, so far as the Trustee and QIB are aware, no person involved in the offer of the Certificates has an interest material to the offer. The Dealer and its affiliates have engaged, and may in the future engage, in investment banking and/or commercial banking transactions with and may perform other services for the Trustee and QIB and (its/their) affiliates in the ordinary course of business. OPERATIONAL INFORMATION (i) ISIN: XS1890047027 (ii) Common Code: 189004702 (iii) Any clearing system(s) other than Euroclear Bank SA/NV and Clearstream Banking S.A. and the relevant identification number(s): Not Applicable (iv) Delivery: Delivery against payment (v) Names and addresses of additional Paying Agent(s) (if any): Not Applicable DISTRIBUTION (i) Method of distribution: (ii) If syndicated: Non-syndicated (A) Names of Managers: Not Applicable (B) Stabilisation Manager(s) (if any): Not Applicable (iii) If non-syndicated, name of Dealer: Standard Chartered Bank (iv) U.S. Selling Restrictions: Reg. S Compliance Category 2; TEFRA not applicable 231861-4-4-v3.0 -5- 75-40701784